China SXT Pharmaceuticals (SXTC) Assets Average: 2020-2025
Historic Assets Average for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Mar 2025 value amounting to $22.4 million.
- China SXT Pharmaceuticals' Assets Average fell 11.28% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year decrease of 11.28%. This contributed to the annual value of $22.4 million for FY2025, which is 14.98% down from last year.
- According to the latest figures from FY2025, China SXT Pharmaceuticals' Assets Average is $22.4 million, which was down 14.98% from $26.3 million recorded in FY2024.
- In the past 5 years, China SXT Pharmaceuticals' Assets Average registered a high of $34.0 million during FY2022, and its lowest value of $22.4 million during FY2025.
- Its 3-year average for Assets Average is $26.8 million, with a median of $26.3 million in 2024.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Assets Average skyrocketed by 43.59% in 2021, and later declined by 16.51% in 2024.
- Yearly analysis of 5 years shows China SXT Pharmaceuticals' Assets Average stood at $28.1 million in 2021, then climbed by 21.06% to $34.0 million in 2022, then dropped by 7.33% to $31.6 million in 2023, then declined by 16.51% to $26.3 million in 2024, then fell by 14.98% to $22.4 million in 2025.